Stocks and Investing Stocks and Investing
Wed, February 28, 2024

Serge Belanger Reiterated (VRDN) at Strong Buy and Held Target at $30 on, Feb 28th, 2024


Published on 2024-10-28 09:15:22 - WOPRAI, Serge Belanger
  Print publication without navigation


Serge Belanger of Needham, Reiterated "Viridian Therapeutics, Inc." (VRDN) at Strong Buy and Held Target at $30 on, Feb 28th, 2024.

Serge has made no other calls on VRDN in the last 4 months.



There are 4 other peers that have a rating on VRDN. Out of the 4 peers that are also analyzing VRDN, 0 agree with Serge's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Serge


  • Leland Gershell of "Oppenheimer" Maintained at Buy with Increased Target to $36 on, Tuesday, December 19th, 2023
  • Douglas Tsao of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $37 on, Monday, December 18th, 2023
  • Gregory Renza of "RBC Capital" Reiterated at Buy and Held Target at $35 on, Thursday, December 14th, 2023
  • Jason Butler of "JMP Securities" Maintained at Buy with Decreased Target to $38 on, Tuesday, November 14th, 2023
Contributing Sources